Drug-in-cyclodextrin-in-liposomes: A promising delivery system for hydrophobic drugs

Expert Opinion on Drug Delivery

Volumn 11, Issue 4, 2014, Pages 565-577

  Chen, Jun ^a   Lu, Wen Li ^b   Gu, Wei ^a   Lu, Shan Shan ^a   Chen, Zhi Peng ^a   Cai, Bao Chang ^a   Yang, Xi Xiong ^c  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c Jingmen Institute of Professional Technology   (China)

Author keywords

Cyclodextrin; Double loading; Liposomes; Stability

Indexed keywords

[5 ACRIDIN 9 YLMETHYLENE 3 (4 METHYLBENZYL) THIAZOLIDINE 2,4 DIONE]; ACRIDINE; AMPHOTERICIN B; ANTINEOPLASTIC AGENT; BENZOCAINE; BUTYLCAINE; CARBENE; CYCLODEXTRIN; CYCLOSPORIN A; DOXORUBICIN; GEFITINIB; HONOKIOL; INDOMETACIN; LIPOSOME; MELOXICAM; MEMBRANE LIPID; PHOSPHATIDYLCHOLINE; POLYMER; QUERCETIN; RESVERATROL; UNCLASSIFIED DRUG; VERAPAMIL;

ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; BREAST CANCER; CELL VACUOLE; DEHYDRATION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; HUMAN; HYDROPHOBIC INTERACTION CHROMATOGRAPHY; IC 50; IN VIVO STUDY; LIPID COMPOSITION; NONHUMAN; REHYDRATION; REVIEW; TRANSDERMAL DRUG ADMINISTRATION;

ANIMALS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CYCLODEXTRINS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HUMANS; LIPOSOMES; SOLUBILITY;

EID: 84897881123     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2014.884557     Document Type: Review

References (66)

1. Otero-Espinar FJ, Torres-Labandeira JJ, Blanco-Mendez J, et al. Cyclodextrins in drug delivery systems. J Drug Del Sci Tech 2010;20(4):289-301
2. Zhang J, Ma PX. Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective. Adv Drug Deliv Rev 2013;65(9):1215-33
3. Lu Y, Guo T, Qi J, et al. Enhanced dissolution and stability of lansoprazole by cyclodextrin inclusion complexation: preparation, characterization, and molecular modeling. AAPS Pharm Sci Tech 2012;13(4):1222-9
4. Ozdemir N, Erkin J. Enhancement of dissolution rate and bioavailability of sulfamethoxazole by complexation with beta-cyclodextrin. Drug Dev Ind Pharm 2012;38(3):331-40
5. McCormack B, Gregoriadis G. Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-/3-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery. Biochim Biophys Acta 1996;1291:237-44
6. Hiasa Y, Ohshima M, Kitahori Y, et al. Beta-cyclodextrin: promoting effect on the development of renal tubular cell tumors in rats treated with N-ethyl- N-hydroxyethylnitrosamine. J Natl Cancer Inst 1982;69(4):963-7
7. Loftsson T, Jarho P, Masson M, et al. Cyclodextrins in drug delivery. Expert Opin Drug Deliv 2005;2(2):335-51
8. Ohtani Y, Irie T, Uekama K, et al. Differential effects of alpha-, beta-, and gamma-cyclodextrins on human erythrocytes. Eur J Biochem 1989;186:17-22
9. Kiss T, Fenyvesi F, Bacskay I, et al. Evaluation of the cytotoxicity of betacyclodextrin derivatives: evidence for the role of cholesterol extraction. Eur J Pharm Sci 2010;40(4):376-80
10. Arias JL. Liposomes in drug delivery: a patent review (2007 - present). Expert Opin Ther Patents 2013;23(11):1399-414
11. Qian S, Li C, Zuo Z. Pharmacokinetics and disposition of various drug loaded liposomes. Curr Drug Metab 2012;13(4):372-95
12. Mccormack B, Gregoriadis G. Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery. J Drug Target 1994;2:449-54
13. Jain SK, Gupta Y, Jain A, et al. Elastic liposomes bearing meloxicam-betacyclodextrin for transdermal delivery. Curr Drug Deliv 2008;5:207-14
14. Machut-Binkowski C, Hapiot F, Cecchelli R, et al. A versatile liposome/cyclodextrin supramolecular carrier for drug delivery through the blood-brain barrier. J Incl Phenom Macrocycle Chem 2007;57:567-72
15. Puglisi G, Fresta M, Ventura CA. Interaction of natural and modified-beta-cyclodextrins with biological membrane model of dipalmitoylphosphatidylcholine. J Colloid Interface Sci 1996;180:542-7
16. Nishijo J, Mizuno H. Interactions of cyclodextrins with DPPC liposomes. Differential scanning calorimetry studies. Chem Pharm Bull 1998;46(1):120-4
17. Puskas I, Csempesz F. Influence of cyclodextrins on the physical stability of DPPC-liposomes. Colloids Surf B Biointerfaces 2007;58:218-24
18. Piel G, Piette M, Barillaro V, et al. Study of the relationship between lipid binding properties of cyclodextrins and their effect on the integrity of liposomes. Int J Pharm 2007;338:35-42
19. Ascenso A, Cruz M, Euleterio C, et al. Novel tretinoin formulations: a drug-incyclodextrin- in-liposome approach. J Liposome Res 2013;23(3):211-19
20. Grammenos A, Bahri MA, Guelluy PH, et al. Quantification of randomlymethylated- b-cyclodextrin effect on liposome: an ESR study. Biochem Biophys Res Commun 2009;390:5-9
21. Hatzi P, Mourtas S, Klepetsanis PG, et al. Integrity of liposomes in presence of cyclodextrins: effect of liposome type and lipid composition. Int J Pharm 2007;333:167-76
22. Piel G, Piette M, Barillaro V, et al. Betamethasone-in-cyclodextrin- inliposome: the effect of cyclodextrins on encapsulation efficiency and release kinetics. Int J Pharm 2006;312:75-82
23. Lapenda TL, Morais WA, Almeida FJ, et al. Encapsulation of transdehydrocrotonin in liposomes: an enhancement of the antitumor activity. J Biomed Nanotechnol 2013;9(3):499-510
24. Sanchez SA, Gunther G, Tricerri MA, et al. Methyl-beta-cyclodextrins preferentially remove cholesterol from the liquid disordered phase in giant unilamellar vesicles. Membrane Biol 2011;241:1-10
25. Lim HJ, Cho EC, Shim J, et al. Polymer-associated liposomes as a novel delivery system for cyclodextrin-bound drugs. J Colloid Interf Sci 2008;320:460-8
26. Besenicar MP, Bavdek A, Kladnik A, et al Kinetics of cholesterol extraction from lipid membranes by methyl-betacyclodextrin- a surface plasmon resonance approach. Biochim Biophys Acta 2008 1778 175-84
27. Van den Hoven JM, Metselarr JM, Storm G, et al. Cyclodextrin as membrane protectant in spray-drying and freeze-drying of PEGylated liposomes. Int J Pharm 2012;438:209-16
28. Rahman S, Cao S, Steadman KJ, et al. Native and beta-cyclodextrin- enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer. Drug Deliv 2012;19(7):346-53
29. Dhule SS, Penfornis P, Frazier T, et al. Curcumin-loaded gamma-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomedicine 2012;8:440-51
30. Gille A, Lecomte F, Hubert P, et al. Skin penetration behaviour of liposomes as a function of their composition. Eur J Pharm Biopharm 2011;79:43-53
31. Cavalcanti IMF, Mendon EAM, Lira MCB, et al. The encapsulation of beta-lapachone in 2-hydroxypropyl-betacyclodextrin inclusion complex into liposomes: a physicochemical evaluation and molecular modeling approach. Eur J Pharm Sci 2011;44:332-40
32. Kaur N, Puri R, Jain SK. Drug-cyclodextrin-vesicles dual carrier approach for skin targeting of anti-acne agent. AAPS Pharm Sci Tech 2010;11(2):528-37
33. Lira MCB, Ferraz MS, da Silva D, et al. Inclusion complex of usnic acid with b-cyclodextrin: characterization and nanoencapsulation into liposomes. J Incl Phenom Macrocycl Chem 2009;64:215-24
34. Zhu Q, Guo T, Xia D, et al. Pluronic F127-modified liposome-containing tacrolimus-cyclodextrin inclusion complexes: improved solubility, cellular uptake and intestinal penetration. J Pharm Pharmcol 2013;65:1107-17
35. Kauscher U, Stuart MCA, Drucker P, et al. Incorporation of amphiphilic cyclodextrins into liposomes as artificial receptor units. Langmuir 2013;29(24):7377-83
36. Kirby C, Gregoriadis G. Dehydration-rehydration vesicles: a simple method for high yield drug entrapment in liposomes. Nat Biotechnol 1984;2:979-84
37. Gasbarri C, Guernelli S, Boncompagni S, et al. Fine-tuning of POPC liposomal leakage by the use of beta-cyclodextrin and several hydrophobic guests. J Liposome Res 2010;20:(3):202-10
38. Agashe H, Lagisetty P, Sahoo K, et al. Liposome-encapsulated EF24-HPbetaCD inclusion complex: a preformulation study and biodistribution in a rat model. J Nanopart Res 2011;13(6):2609-23
39. Gubernator J. Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity. Expert Opin Drug Deliv 2011;8(5):565-80
40. Arima H, Hagiwara Y, Hirayama F, et al. Enhancement of antitumor effect of doxorubicin by its complexation with gamma-cyclodextrin in pegylated liposomes. J Drug Target 2006;14(4):225-32
41. Zhou X, Yung B, Huang Y, et al. Novel liposomal gefitinib (L-GEF) formulations. Anticancer Res 2012;32:2919-24
42. Cui J, Li C, Wang C, et al. Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage? J Pharm Sci 2011;100(7):2835-48
43. Modi S, Xiang TX, Anderson BD. Enhanced active liposomal loading of a poorly soluble ionizable drug using supersaturated drug solutions. J Control Release 2012;162:330-9
44. Skalko-Basnet N, Pavelic Z, Becirevic-Lacan M. Liposomes containing drug and cyclodextrin prepared by the one-step spray-drying method. Drug Dev Ind Pharm 2000;26(12):1279-84
45. Wang X, Deng L, Cai L, et al. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-betacyclodextrin- in-liposome. J Pharm Sci 2011;100(8):3357-64
46. Maestrelli F, Gonzalez-Rodrguez ML, Rabasco AM, et al. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery. Int J Pharm 2006;312:53-60
47. Jain SK, Gupta Y, Jain A, et al. Multivesicular liposomes bearing celecoxib-beta-cyclodextrin complex for transdermal delivery. Drug Deliv 2007;14:327-35
48. Mendonca EAM, Lira MCB, Rabello MM, et al. Enhanced antiproliferative activity of the new anticancer candidate LPSF/AC04 in cyclodextrin inclusion complexes encapsulated into liposomes. AAPS PharmSciTech 2012;13(4):1355-66
49. Maestrelli F, Gonzalez-Rodrguez ML, Rabasco AM, et al. Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery. Int J Pharm 2005;298:55-67
50. Fatouros DG, Hatzidimitriou K, Antimisiaris S, et al. Liposomes encapsulating prednisolone and prednisolone-cyclodextrin complexes: comparison of membrane integrity and drug release. Eur J Pharm Sci 2001;13(3):287-96
51. Chakraborty KK, Naik SR. Therapeutic and hemolytic evaluation of in-situ liposomal preparation containing amphotericin-beta complexed with different chemically modified beta-cyclodextrins. J Pharm Pharm Sci 2003;6(2):231-7
52. Chen H, Gao J, Wang F, et al. Preparation, characterization and pharmacokinetics of liposomes-encapsulated cyclodextrins inclusion complexes for hydrophobic drugs. Drug Deliv 2007;14:201-8
53. Joguparthi V, Anderson BD. Effect of cyclodextrin complexation on the liposome permeability of a model hydrophobic weak Acid. Pharm Res 2008;25(11):2505-15
54. Agashe H, Sahoo K, Lagisetty P, et al. Cyclodextrin-mediated entrapment of curcuminoid 4-[3,5-bis(2- chlorobenzylidene-4-oxo-piperidine-1-yl)- 4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats. Colloids Surf B Biointerfaces 2011;84:329-37
55. Mccormack B, Gregoriadis G. Drugs-incyclodextrins- in-liposomes: an approach to controlling the fate of water insoluble drugs in vivo. Int J Pharm 1998;162:59-69
56. Szebeni J. Complement activation-related pseudoallergy: a new class of druginduced acute immune toxicity. Toxicology 2005;216:106-21
57. Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 2007;332:1-16
58. Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1992;1104:226-32
59. Benson HAE. Transfersomes for transdermaldrug delivery. Expert Opin Drug Deliv 2006;3(6):727-37
60. Chen J, Lu WL, Gu W, et al. Skin permeation behavior of elastic liposomes: role of formulation ingredients. Expert Opin Drug Deliv 2013;10(6):845-56
61. Ascenso A, Guedes R, Bernardino R, et al. Complexation and full characterization of the tretinoin and dimethyl-beta-cyclodextrin complex. AAPS Pharm Sci Tech 2011;12:553-63
62. Singh HP, Tiwary AK, Jain S. Preparation and in vitro, in vivo characterization of elastic liposomes encapsulating cyclodextrin-colchicine complexes for topical delivery of colchicines. Yakugaku Zasshi 2010;130(3):397-407
63. Cadena PG, Pereira MA, Cordeiro RBS, et al. Nanoencapsulation of quercetin and resveratrol into elastic liposomes. Biochim Biophys Acta 2013;1828:309-16
64. Nikouei-malaekeh B, Davies N. Double loading of cyclosporine A in liposomes using cyclodextrin complexes. PDA J Pharm Sci Tech 2009;63(2):139-48
65. Bragagni M, Maestrelli F, Mennini N, et al. Liposomal formulations of prilocaine: effect of complexation with hydroxypropyl-beta-cyclodextrin on drug anesthetic efficacy. J Liposome Res 2010;20(4):315-22
66. Maestrelli F, Gonzalez-Rodrguez ML, Rabasco AM. New "drug-in cyclodextrinin deformable liposomes" formulations to improve the therapeutic efficacy of local anaesthetics. Int J Pharm 2010;395:222-31